Table 2.
UD | LD-Stable | LD-Unstable | Overall | |
---|---|---|---|---|
No. pts | 419 | 93 | 54 | 566 |
No. BCR events (%) | 27 (6) | 7 (7) | 37 (68) | 71 (12) |
No. BCR surgery type: | ||||
ORP | 26 | 5 | 15 | 46 |
RARP | 1 | 2 | 22 | 25 |
No. XRT for PSA less than 0.2 ng/ml | 2 | 2 | 7 | 11 |
No. XRT | 13 | 4 | 24 | 41 |
No. ADT | 4 | 1 | 2 | 7 |
No. XRT/ADT | 1 | 0 | 1 | 2 |
No. metastasis | 3 | 0 | 1 | 4 |
No. death | 36 | 0 | 2 | 38 |
No. prostate Ca death | 1 | 0 | 0 | 1 |
Median followup (mos) | 85 | 69 | 84 | – |
Median followup to PSA greater than 0.2 ng/ml (mos) | 84 | 96 | 51 | – |
% 7-yr BCR-free survival | 95.1 | 94.5 | 37.3 | – |